← Leaderboards
John M Dye
Geneva Foundation
$3,551,522
Attributed
$3,551,522
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $917.3K · FY2014–18$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,551,522 · 1
By mechanism
R01$3,551,522 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “General Population”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$97,058,880
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$92,672,234
- Judith S. Currier · University Of California Los Angeles$92,372,234
- Peter Gordon Gillespie · Oregon Health And Science University$79,485,491
- Constance Ann Benson · University Of California, San Diego$65,790,143
Research focus
General PopulationAntibodiesFda ApprovedFamilyAntigensAreaBaseAntibody TherapyAfricaEvaluationBiologicalBioterrorismCategoriesCessation Of LifeDemocratic Republic Of The CongoDesignDisease OutbreaksDoseDrug KineticsEbola VirusBiodefenseEfficacy TestingEfficacy TrialHalf-Life
Grant awards (5)
Mammalian and Plant-derived Antibody-based Therapies against Sudan Ebolavirus$786,345
R01 · FY2018 · AI · contact PI
Mammalian and Plant-derived Antibody-based Therapies against Sudan Ebolavirus$917,343
R01 · FY2017 · AI · contact PI
Mammalian and Plant-derived Antibody-based Therapies against Sudan Ebolavirus$766,924
R01 · FY2016 · AI · contact PI
Mammalian and Plant-derived Antibody-based Therapies against Sudan Ebolavirus$478,167
R01 · FY2015 · AI · contact PI
Mammalian and Plant-derived Antibody-based Therapies against Sudan Ebolavirus$602,743
R01 · FY2014 · AI · contact PI